Dexamethasone May Curb Efficacy of Immune Checkpoint Blockade in Glioblastoma Dexamethasone May Curb Efficacy of Immune Checkpoint Blockade in Glioblastoma

Dexamethasone given to combat cerebral edema in patients with glioblastoma may negatively affect immunotherapy, according to work in mice and clinical data.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news